25736-86-1

Basic information

• Product Name: POLY(ETHYLENE GLYCOL) (N) MONOMETHACRYLATE
• Synonyms: Poly(oxy-1,2-ethanediyl),.alpha.-(2-methyl-1-oxo-2-propenyl)-.omega.-hydroxy-;POLY(ETHYLENE GLYCOL) METHACRYLATE, AVER AGE MN CA. 526;POLY(ETHYLENE GLYCOL) METHACRYLATE, AVER AGE MN CA. 360;ETHOXYLATEDHYDROXYETHYLMETHACRYLATE;α-(2-Methyl-1-oxo-2-propenyl)-ω-hydroxy-poly(oxy-1,2-ethanediyl);POLY(ETHYLENE GLYCOL) METHACRYLATE, AVERAGE 360;POLY(ETHYLENE GLYCOL) METHACRYLATE, AVERAGE 526;Poly(ethylene glycol) Methacrylate average Mn 360, contains 500-800 ppM MEHQ as inhibitor
• CAS NO: 25736-86-1
• Molecular Formula: C24H46O12
• Molecular Weight: 526.61
• EINECS: 210-909-6
• Product Categories: Heterobifunctional PEGs;Poly(ethylene glycol) and Poly(ethylene oxide);Polymer Science;Heterobifunctional PEGs;Materials Science;Poly(ethylene glycol) and Poly(ethylene oxide);Polymer Science;Polymers
• Mol File: 25736-86-1.mol
• Article Data: 50

Chemical Properties

• Boiling Point: >300°C
• Flash Point: >230 °F
• Appearance: /
• Density: 1.105 g/mL at 25 °C
• Refractive Index: n20/D 1.467
• CAS DataBase Reference: POLY(ETHYLENE GLYCOL) (N) MONOMETHACRYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: POLY(ETHYLENE GLYCOL) (N) MONOMETHACRYLATE(25736-86-1)
• EPA Substance Registry System: POLY(ETHYLENE GLYCOL) (N) MONOMETHACRYLATE(25736-86-1)

Safety Data

• Hazard Codes: Xi
• Statements: 38
• Safety Statements: 26-36/37/39
• WGK Germany: 3
• Hazardous Substances Data: 25736-86-1(Hazardous Substances Data)

Usage

Description

POLY(ETHYLENE GLYCOL) (N) MONOMETHACRYLATE is a versatile polymer that is commonly used in various applications due to its unique properties. It is a monomer that can be polymerized to form poly(ethylene glycol) (PEG)-based polymers, which are known for their biocompatibility, non-toxicity, and flexibility. The polymer may darken upon storage, which is a characteristic to be aware of when handling and storing the material.

Uses

Used in Emulsion Polymerization:
POLY(ETHYLENE GLYCOL) (N) MONOMETHACRYLATE is used as a comonomer in emulsion polymerization for its ability to improve the properties of the resulting polymers. It enhances the solubility, flexibility, and compatibility of the polymers, making them suitable for a wide range of applications.
Used in Pharmaceutical Industry:
POLY(ETHYLENE GLYCOL) (N) MONOMETHACRYLATE is used as a thickener, dispersant, and suspending aid in the pharmaceutical industry. Its biocompatibility and non-toxic nature make it an ideal candidate for use in drug formulations, where it can help improve the stability, solubility, and overall performance of the drug.
Used in Cosmetics Industry:
In the cosmetics industry, POLY(ETHYLENE GLYCOL) (N) MONOMETHACRYLATE is used as a thickener, dispersant, and suspending aid for various cosmetic products. Its ability to improve the texture, consistency, and stability of formulations makes it a valuable ingredient in the development of creams, lotions, and other personal care products.
Used in Biomedical Applications:
POLY(ETHYLENE GLYCOL) (N) MONOMETHACRYLATE is also used in biomedical applications, such as in the development of hydrogels and other biomaterials. Its biocompatibility and ability to form stable structures make it a promising material for use in tissue engineering, drug delivery systems, and other medical applications.

InChI:InChI=1/C6H10O3/c1-5(2)6(8)9-4-3-7/h7H,1,3-4H2,2H3

Upstream product

• 107-21-1 ethylene glycol 
• 80-62-6 methacrylic acid methyl ester 
• 920-46-7 Methacryloyl chloride 
• 2421-28-5 dianhydride of benzophenone-3,4,3',4'-tetracarboxy acid 
• 111-46-6 diethylene glycol 
• 107-07-3 2-chloro-ethanol 
• 79-41-4 poly(methacrylic acid) 
• 75-21-8 oxirane 
• 112-60-7 Tetraethylene glycol 
• 112-27-6 2,2'-[1,2-ethanediylbis(oxy)]bisethanol 
• 92-84-2 10H-phenothiazine 
• 21282-97-3 2-(methacryloyloxy)ethyl acetoacetate 
• 1269794-11-7 2,2-(2-nitro-1,4-phenylene)bis(methylene)bis(oxy) bis(oxomethylene)bis(oxy)bis(ethane-2,1-diyl) bis(2-methylacrylate) 
• 20166-49-8 2-acetoxyethyl methylacrylate 

Downstream Products

• 19117-13-6 2-Methyl-acrylic acid 2-(heptyl-{4-[1-(4-{heptyl-[2-(2-methyl-acryloyloxy)-ethoxy]-phosphinoyloxy}-phenyl)-1-methyl-ethyl]-phenoxy}-phosphinoyloxy)-ethyl ester 
• 13695-27-7 ethylene glycol monomethacrylate chloroformate 
• 91375-72-3 <(2'-chlorocarbonyloxy)ethyl>-2-methyl-3-chloropropionate 
• 105501-11-9 sodium 2,3-bis(hexadecyloxy)propyl 3-methacryloyl-3-oxapropyl phosphate 
• 132153-56-1 2-methacryloyloxyethyl-D-mannoside 
• 132153-62-9 2-glucosyloxyethyl methacrylate 
• 132153-65-2 galactosyloxyethyl methacrylate 
• 108595-19-3 1-hexa-2t,4t-dienyloxy-2-methacryloyloxy-ethane 
• 17407-12-4 dimethyl-di(methacroyloxy-1-ethoxy)silane 
• 51293-89-1 2-methylacrylic acid 2-(butylcarbamoyloxy)ethyl ester 
• 69040-48-8 ethylene glycol acrylate methacrylate 
• 41261-99-8 cinnamoyloxyethyl methacrylate 
• 1449577-85-8 2-(methacryloyloxy) ethyl 3,5-difluorobenzoate 
• 1449577-86-9 2-(methacryloyloxy) ethyl 3,5-bis(trifluoromethyl)benzoate 

Relevant articles and documents

Protein-Grafted Polymers Prepared Through a Site-Specific Conjugation by Microbial Transglutaminase for an Immunosorbent Assay

Protein-polymer conjugates have been developed in many fields. Most hybrids are composed of one protein attached to one or several polymer chains. The other form of hybrid involves the construction of multiple proteins on one polymer chain, thereby facili

Acrylate monomer having hydrophilic end group and a method for preparing the same

More particularly, the present invention relates to an acrylate monomer having a high-purity hydrophilic terminal group which does not contain unreacted 1 water or undesirable by-products, and a method for producing the acrylate monomer. These acrylate monomers are substantially free of polymerization inhibitors. Chemical Formula 1. In Chemical Formula 1, R. 1 Chem. R. 2 Chem. R. 3 May be H, or linear, branched or cyclic C, independently of each other. 1 -C12 alkyl group. R4 Is linear, branched or cyclic C. 1 -C12 alkyl Or C1 -C12 It is alkoxy group, wherein alkyl group carbon atoms can be unsubstituted or substituted with oxygen atoms, n Is an integer selected from 1 and 10.

BIOGUM AND BOTANICAL GUM HYDROGEL BIOINKS FOR THE PHYSIOLOGICAL 3D BIOPRINTING OF TISSUE CONSTRUCTS FOR IN VITRO CULTURE AND TRANSPLANTATION

Bioink compositions comprising a biomaterial (mammalian, plant based, synthetically derived, or microbially derived) such as a hydrogel and a microbial-, fungal-, or plant-produced polysaccharide, with or without cells, for use in the 3D bioprinting of human tissues and scaffolds are described. The bioink compositions have excellent printability and improved cell function, viability and engraftment. Furthermore, the bioink compositions can be supplemented through the additional of auxiliary proteins and other molecules such as growth factors including extracellular matrix components, Laminins, super affinity growth factors and morphogens. The bioink compositions can be used under physiological conditions related to 3D bioprinting parameters which are cytocompatible (e.g. temperature, printing pressure, nozzle size, bioink gelation process). The combination of a biogum-based biomaterial together with mammalian, plant, microbial or synthetically derived hydrogels exhibited improvement in printability, cell function and viability compared to tissues printed with bioink not containing biogums.

All-cell tumor nano vaccine Preparation method and application thereof

The invention relates to a whole-cell tumor nano vaccine and a preparation method and application thereof. The whole-cell tumor nano vaccine is a nano-vaccine of an acid-sensitive polymer-loaded immunoadjuvant, a nano-vaccine of an acid-sensitive polymer - immunologic adjuvant conjugate, a nano vaccine coated with an engineering tumor cell membrane, or a combination of the two. To the whole-cell tumor nano vaccine, dendritic cell antigen presenting efficiency can be enhanced, multiple specific cytotoxic T lymphocytes are activated, efficient anti-tumor recurrence and transfer effects are achieved, and meanwhile, personalized treatment of malignant tumors is facilitated.